WatchPAT: Proven to Detect Residual Sleep-Disordered Breathing in Patients on CPAP
The incidence of obstructive sleep apnea syndrome (OSA) is estimated to be 25% in the adult population. That’s one-quarter of
The incidence of obstructive sleep apnea syndrome (OSA) is estimated to be 25% in the adult population. That’s one-quarter of
December 16, 2021 — CHELMSFORD, MASS. — ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions,
Join us virtually to learn more about helping your sleep apnea patients. Learn best practices to efficiently screen for sleep
(January 2013) Itamar Medical has discontinued the production of Watch-PAT100. Itamar Medical will continue supporting the Watch-PAT100 product for a
As a customer of the Itamar Medical Ltd., through your purchase of the WatchPAT200™ SN: 3xxxx Model, we want to
We would like to inform you that starting May 30th 2016, the following items will be discontinued:1. Integrated Snoring +
Dear WatchPAT Customer, Itamar Medical is continuing its commitment to diagnosing and managing sleep disordered breathing by delivering cost effective
We are pleased to announce the release of CloudPAT v2.8, effective July 8th, 2019. This release is aligned with the
Cleaning the WatchPAT and its accessories (Snoring and Body Position sensor and Respiratory Effort and Snoring and Body Position sensor)